GenixCure

NEWS & NOTICE

Notice
News

NEWS

Presented ‘Engineering Next-Generation AAV Vectors for Enhanced ALS Therapy’ at SfN 2024

2024-10-22
Awarded at ‘G-Star Audition Scale-Up’ Global Startup IR Competition

2024-10-22
'Korea Investment Week 2024' Participation

2024-09-23
Signed a MOU with Modalis Therapeutics Corporation, jointly developing a XOB031-mediated AAV gene therapy for Alzheimer’s disease

2024-07-12
GXC-301 ODD request granted by US FDA

2024-07-02
GENIXCURE, Selected as a ‘2024 Global Unicorn’

2024-06-26
GXC-301 RPDD request granted by US FDA

2024-05-31
2024 Top Cell&Gene Therapy Company Award By Life Sciences Review

2024-05-30
A ‘co-developing’ Alzheimer’s disease therapeutic program with Hanyang Univ., funded by a governmental global R&D program from KHIDI

2024-04-23